IN THE NEWS: MDT leader, Dr. Yang on the Current Treatment Landscape in MCL


Jay Yang, M.D., leader of the Hematology Oncology Multidisciplinary Team at Karmanos Cancer Institute explains that most mantle cell lymphoma (MCL) patients will need treatment although there is not a true standard of care for the disease.

Read the full article here.